The lancet. Gastroenterology & hepatology最新文献

筛选
英文 中文
Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference randomised trial. 短期手术封闭抗肿瘤坏死因子治疗与抗肿瘤坏死因子治疗克罗恩病肛周瘘(PISA-II):一项患者偏好随机试验
The lancet. Gastroenterology & hepatology Pub Date : 2022-04-01 DOI: 10.1016/s2468-1253(22)00088-7
E. M. Meima-van Praag, K. V. van Rijn, K. Wasmann, H. J. Snijder, J. Stoker, G. D'Haens, K. Gecse, M. Gerhards, J. M. Jansen, M. Dijkgraaf, J. V. D. van der Bilt, M. Mundt, A. Spinelli, S. Danese, W. Bemelman, C. Buskens
{"title":"Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference randomised trial.","authors":"E. M. Meima-van Praag, K. V. van Rijn, K. Wasmann, H. J. Snijder, J. Stoker, G. D'Haens, K. Gecse, M. Gerhards, J. M. Jansen, M. Dijkgraaf, J. V. D. van der Bilt, M. Mundt, A. Spinelli, S. Danese, W. Bemelman, C. Buskens","doi":"10.1016/s2468-1253(22)00088-7","DOIUrl":"https://doi.org/10.1016/s2468-1253(22)00088-7","url":null,"abstract":"","PeriodicalId":114609,"journal":{"name":"The lancet. Gastroenterology & hepatology","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121212399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Shining a light on international alcohol industry lobbying. 揭露国际酒精行业的游说活动。
The lancet. Gastroenterology & hepatology Pub Date : 2022-04-01 DOI: 10.1016/s2468-1253(22)00060-7
The Lancet Gastroenterology & Hepatology
{"title":"Shining a light on international alcohol industry lobbying.","authors":"The Lancet Gastroenterology & Hepatology","doi":"10.1016/s2468-1253(22)00060-7","DOIUrl":"https://doi.org/10.1016/s2468-1253(22)00060-7","url":null,"abstract":"","PeriodicalId":114609,"journal":{"name":"The lancet. Gastroenterology & hepatology","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123427987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Navigating the unknowns of idiopathic pancreatitis 探索特发性胰腺炎的未知因素
The lancet. Gastroenterology & hepatology Pub Date : 2022-03-09 DOI: 10.1016/s2468-1253(22)00058-9
Eleanor Crichton
{"title":"Navigating the unknowns of idiopathic pancreatitis","authors":"Eleanor Crichton","doi":"10.1016/s2468-1253(22)00058-9","DOIUrl":"https://doi.org/10.1016/s2468-1253(22)00058-9","url":null,"abstract":"","PeriodicalId":114609,"journal":{"name":"The lancet. Gastroenterology & hepatology","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126508710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of sofosbuvir-velpatasvir-voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment failure in Rwanda (SHARED-3): a single-arm trial. 在卢旺达,sofosbuvir-velpatasvir-voxilaprevir用于既往直接作用抗病毒治疗失败的慢性丙型肝炎病毒感染患者再治疗的安全性和有效性(share -3):一项单臂试验。
The lancet. Gastroenterology & hepatology Pub Date : 2022-03-01 DOI: 10.1016/S2468-1253(21)00399-X
N. Gupta, Linda Manirambona, Fabienne Shumbusho, Jules Kabihizi, Anthere Murangwa, J. Serumondo, J. D. Makuza, S. Nsanzimana, C. Muvunyi, Constance Mukabatsinda, E. Musabeyezu, G. Camus, P. Grant, F. Kateera
{"title":"Safety and efficacy of sofosbuvir-velpatasvir-voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment failure in Rwanda (SHARED-3): a single-arm trial.","authors":"N. Gupta, Linda Manirambona, Fabienne Shumbusho, Jules Kabihizi, Anthere Murangwa, J. Serumondo, J. D. Makuza, S. Nsanzimana, C. Muvunyi, Constance Mukabatsinda, E. Musabeyezu, G. Camus, P. Grant, F. Kateera","doi":"10.1016/S2468-1253(21)00399-X","DOIUrl":"https://doi.org/10.1016/S2468-1253(21)00399-X","url":null,"abstract":"","PeriodicalId":114609,"journal":{"name":"The lancet. Gastroenterology & hepatology","volume":"220 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128343750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Research in Brief. 简要研究。
The lancet. Gastroenterology & hepatology Pub Date : 2022-03-01 DOI: 10.1016/s2468-1253(22)00016-4
H. Baker
{"title":"Research in Brief.","authors":"H. Baker","doi":"10.1016/s2468-1253(22)00016-4","DOIUrl":"https://doi.org/10.1016/s2468-1253(22)00016-4","url":null,"abstract":"","PeriodicalId":114609,"journal":{"name":"The lancet. Gastroenterology & hepatology","volume":"7 3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130988532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global multi-stakeholder endorsement of the MAFLD definition. 全球多利益攸关方对MAFLD定义的认可。
The lancet. Gastroenterology & hepatology Pub Date : 2022-03-01 DOI: 10.1016/S2468-1253(22)00062-0
N. Méndez-Sánchez, E. Bugianesi, R. Gish, F. Lammert, H. Tilg, M. Nguyen, S. Sarin, N. Fabrellas, S. Zelber-Sagi, Jian-Gao Fan, G. Shiha, G. Targher, M. Zheng, W. Chan, S. Vinker, T. Kawaguchi, L. Castéra, Y. Yılmaz, Marko Korenjak, C. W. Spearman, M. Ungan, Melissa Palmer, M. El-Shabrawi, H. Gruss, J. Dufour, Anil Dhawan, H. Wedemeyer, J. George, Luca Valenti, Y. Fouad, M. Romero‐Gomez, M. Eslam, Faisal Ismail
{"title":"Global multi-stakeholder endorsement of the MAFLD definition.","authors":"N. Méndez-Sánchez, E. Bugianesi, R. Gish, F. Lammert, H. Tilg, M. Nguyen, S. Sarin, N. Fabrellas, S. Zelber-Sagi, Jian-Gao Fan, G. Shiha, G. Targher, M. Zheng, W. Chan, S. Vinker, T. Kawaguchi, L. Castéra, Y. Yılmaz, Marko Korenjak, C. W. Spearman, M. Ungan, Melissa Palmer, M. El-Shabrawi, H. Gruss, J. Dufour, Anil Dhawan, H. Wedemeyer, J. George, Luca Valenti, Y. Fouad, M. Romero‐Gomez, M. Eslam, Faisal Ismail","doi":"10.1016/S2468-1253(22)00062-0","DOIUrl":"https://doi.org/10.1016/S2468-1253(22)00062-0","url":null,"abstract":"","PeriodicalId":114609,"journal":{"name":"The lancet. Gastroenterology & hepatology","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127403031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 109
First-line chemotherapy plus immunotherapy in biliary tract cancer. 一线化疗加免疫治疗胆道癌。
The lancet. Gastroenterology & hepatology Pub Date : 2022-03-01 DOI: 10.1016/s2468-1253(22)00052-8
C. Neuzillet
{"title":"First-line chemotherapy plus immunotherapy in biliary tract cancer.","authors":"C. Neuzillet","doi":"10.1016/s2468-1253(22)00052-8","DOIUrl":"https://doi.org/10.1016/s2468-1253(22)00052-8","url":null,"abstract":"","PeriodicalId":114609,"journal":{"name":"The lancet. Gastroenterology & hepatology","volume":"61 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132587070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Safety and efficacy of sofosbuvir-velpatasvir to treat chronic hepatitis C virus infection in treatment-naive patients in Rwanda (SHARED-3): a single-arm trial. 索非布韦-维帕他韦治疗卢旺达初治患者慢性丙型肝炎病毒感染的安全性和有效性(SHARED-3):一项单臂试验
The lancet. Gastroenterology & hepatology Pub Date : 2022-03-01 DOI: 10.1016/S2468-1253(21)00398-8
F. Kateera, Fabienne Shumbusho, Linda Manirambona, Jules Kabihizi, Anthere Murangwa, J. Serumondo, J. D. Makuza, S. Nsanzimana, C. Muvunyi, J. D. Kabakambira, Habarurema Sylvain, G. Camus, P. Grant, N. Gupta
{"title":"Safety and efficacy of sofosbuvir-velpatasvir to treat chronic hepatitis C virus infection in treatment-naive patients in Rwanda (SHARED-3): a single-arm trial.","authors":"F. Kateera, Fabienne Shumbusho, Linda Manirambona, Jules Kabihizi, Anthere Murangwa, J. Serumondo, J. D. Makuza, S. Nsanzimana, C. Muvunyi, J. D. Kabakambira, Habarurema Sylvain, G. Camus, P. Grant, N. Gupta","doi":"10.1016/S2468-1253(21)00398-8","DOIUrl":"https://doi.org/10.1016/S2468-1253(21)00398-8","url":null,"abstract":"","PeriodicalId":114609,"journal":{"name":"The lancet. Gastroenterology & hepatology","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124210206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study. AJM300(甲基胡萝卜素),α4整合素的口服拮抗剂,作为中度活动性溃疡性结肠炎患者的诱导治疗:一项多中心、随机、双盲、安慰剂对照的3期研究
The lancet. Gastroenterology & hepatology Pub Date : 2022-03-01 DOI: 10.1016/s2468-1253(22)00022-x
K. Matsuoka, M. Watanabe, T. Ohmori, Koichi Nakajima, T. Ishida, Y. Ishiguro, K. Kanke, K. Kobayashi, Fumihito Hirai, Kenji Watanabe, H. Mizusawa, Shuji Kishida, Yoshiharu Miura, Akira Ohta, T. Kajioka, T. Hibi
{"title":"AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.","authors":"K. Matsuoka, M. Watanabe, T. Ohmori, Koichi Nakajima, T. Ishida, Y. Ishiguro, K. Kanke, K. Kobayashi, Fumihito Hirai, Kenji Watanabe, H. Mizusawa, Shuji Kishida, Yoshiharu Miura, Akira Ohta, T. Kajioka, T. Hibi","doi":"10.1016/s2468-1253(22)00022-x","DOIUrl":"https://doi.org/10.1016/s2468-1253(22)00022-x","url":null,"abstract":"","PeriodicalId":114609,"journal":{"name":"The lancet. Gastroenterology & hepatology","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127048245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Direct-acting antiviral regimens and HCV treatment failure and re-treatment in sub-Saharan Africa. 撒哈拉以南非洲的直接抗病毒治疗方案和丙型肝炎病毒治疗失败和再治疗。
The lancet. Gastroenterology & hepatology Pub Date : 2022-03-01 DOI: 10.1016/S2468-1253(21)00465-9
C. Opio
{"title":"Direct-acting antiviral regimens and HCV treatment failure and re-treatment in sub-Saharan Africa.","authors":"C. Opio","doi":"10.1016/S2468-1253(21)00465-9","DOIUrl":"https://doi.org/10.1016/S2468-1253(21)00465-9","url":null,"abstract":"","PeriodicalId":114609,"journal":{"name":"The lancet. Gastroenterology & hepatology","volume":"77 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126229948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信